Table II.
Adenomyosis without malignant transformation (N=57) | Adenomyosis with malignant transformation (N=7) | P-value | ||
Age (years) | 63 ± 9.3 | 65 ± 10.1 | 0.60 | |
Menopause | 49 (86%) | 7 (100%) | 0.58 | |
Co-existing Fibroids | 24 (42.1%) | 1 (14.3%) | 0.23 | |
Co-existing Endometriosis | 1 (1.8%) | 1 (14.3%) | 0.20 | |
CA125 elevated (>35 U/ml) | 8 (17.8%) | 2 (33.3%) | 0.58 | |
FIGO Stage | 0.57 | |||
I | 51 (89.5%) | 6 (85.7%) | ||
II | 3 (5.3%) | 0 (0%) | ||
III | 2 (3.5%) | 1 (14.3%) | ||
IV | 1 (1.7%) | 0 (0%) | ||
Tumor Grade | 0.19 | |||
1 | 20 (35.1%) | 2 (28.6%) | ||
2 | 33 (57.9%) | 3 (42.8%) | ||
3 | 4 (7%) | 2 (28.6%) |